Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phase II clinical trials initiated for humanized anti-CD3 antibody developed at PDL

Oct. 21, 1999

North American Vaccine awarded contract to supply NeisVac-C in U.K.

Oct. 20, 1999

Chiron Behring, Abbott seek to terminate marketing agreements with North American Vaccines

Oct. 20, 1999

Antisense modulation of LFA-3 jointly investigated by Isis and Yale

Oct. 20, 1999

Trisulfide immunostimulants and their use in arteriosclerosis, etc.

Oct. 19, 1999

Progress toward a universal flu vaccine?

Oct. 18, 1999

RotaShield withdrawn from the market following reports of intussusception

Oct. 18, 1999

Wyeth-Ayerst reports U.S. launch of immunosuppressant

Oct. 18, 1999

Immunogenic compositions for the treatment or prevention of HPV infections from Cantab

Oct. 18, 1999

Ciclosporin derivative SDZ-SCP-764: pharmacokinetics and distribution following inhaled dosing

Oct. 15, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...